InvestorsHub Logo
Followers 4
Posts 104
Boards Moderated 0
Alias Born 02/11/2016

Re: lattices post# 331

Thursday, 03/09/2017 7:00:58 AM

Thursday, March 09, 2017 7:00:58 AM

Post# of 1319
Here's one article that posits the reason shares collapsed: http://host.madison.com/business/investment/markets-and-stocks/here-s-why-trevena-dropped-today/article_1009c089-d99d-5949-810e-3b039810113b.html

It makes a convincing point: The company's expenses will be very high going forward, and they ballooned last year as well. They are about to go a long time with zero revenue and have to get cash -- lots of cash -- from somewhere....and all of this on a drug that will have a small market share.

...However, we knew all this, and the article posits that the 4th Q report reminded the market just how dismal things look -- though all of it was known.

Needham's analyst retained his prior rating and commented that the company's announced their initial marketing focus for Olinvo to just the highest-risk patient set...but, again, we knew all this.

----------

Every day is a chance to learn things, and I remain with the view that Trevena just has many unhappy shareholders, and share weakness, particularly when it comes in a torrent of selling, can make these shareholders feel like can't afford to wait anymore for a better price....but we'll get another lesson today from Mr. Market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TRVN News